Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
VC

VCEL

Market Closed

Vericel Corporation

NASDAQHealthcareBiotechnology
US
398 employees
CEO: Dominick C. Colangelo
Founded: 1997
$40.19
+$0.00(+NaN%)
Market Cap
2.06B
Beta
1.05
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Based on PERT weighted analysis (confidence: high), the fair value is $19.36, implying 52.5% downside from current levels. The stock appears significantly overvalued. Financial health scores indicate moderate fundamentals (2.8/5). Monte Carlo analysis shows low downside risk (0% of scenarios below current price). Overall, this suggests a elevated valuation risk at current prices.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore VCEL

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

VCEL in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →